- Home
- COGT vs PARR Comparison
COGT vs PARR Comparison
Compare COGT & PARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COGT
- PARR
- Stock Information
- Founded
- COGT 2014
- PARR 1984
- Country
- COGT United States
- PARR United States
- Employees
- COGT N/A
- PARR N/A
- Industry
- COGT Biotechnology: Pharmaceutical Preparations
- PARR Integrated oil Companies
- Sector
- COGT Health Care
- PARR Energy
- Exchange
- COGT Nasdaq
- PARR Nasdaq
- Market Cap
- COGT 984.0M
- PARR 903.1M
- IPO Year
- COGT 2018
- PARR N/A
- Fundamental
- Price
- COGT $8.90
- PARR $17.64
- Analyst Decision
- COGT Buy
- PARR Buy
- Analyst Count
- COGT 6
- PARR 6
- Target Price
- COGT $14.67
- PARR $28.00
- AVG Volume (30 Days)
- COGT 1.3M
- PARR 1.0M
- Earning Date
- COGT 11-12-2024
- PARR 11-04-2024
- Dividend Yield
- COGT N/A
- PARR N/A
- EPS Growth
- COGT N/A
- PARR N/A
- EPS
- COGT N/A
- PARR 5.32
- Revenue
- COGT N/A
- PARR $8,325,746,999.00
- Revenue This Year
- COGT N/A
- PARR N/A
- Revenue Next Year
- COGT N/A
- PARR N/A
- P/E Ratio
- COGT N/A
- PARR $3.32
- Revenue Growth
- COGT N/A
- PARR 5.96
- 52 Week Low
- COGT $3.67
- PARR $14.84
- 52 Week High
- COGT $12.61
- PARR $40.70
- Technical
- Relative Strength Index (RSI)
- COGT 28.97
- PARR 55.44
- Support Level
- COGT $9.97
- PARR $16.46
- Resistance Level
- COGT $11.16
- PARR $17.69
- Average True Range (ATR)
- COGT 0.78
- PARR 0.89
- MACD
- COGT -0.25
- PARR 0.29
- Stochastic Oscillator
- COGT 2.02
- PARR 88.19
About COGT Cogent Biosciences Inc.
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with strong dependence on oncogenic KIT signaling.
About PARR Par Pacific Holdings Inc.
Par Pacific Holdings Inc is an oil and gas company that manages and maintains interests in energy and infrastructure businesses. The company has three reportable segments namely Refining, Under its refining business, the company produces ultra-low-sulfur diesel, gasoline, jet fuel, marine fuel, LSFO, and other associated refined products. Its Retail includes operation licenses out brands to serve the retail consumer. Through the Logistics segment, crude shipments are delivered to the refineries, in addition to finished products that are exported. It generates maximum revenue from the Refining segment.